Spineway SA (ALSPW.PA)

EUR 0.11

(-1.54%)

Market Cap (In EUR)

87.05 Thousand

Revenue (In EUR)

10.51 Million

Net Income (In EUR)

-6.51 Million

Avg. Volume

2.17 Million

Currency
EUR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.073-30.0
PE
-0.13
EPS
-0.82
Beta Value
1.477
ISIN
FR001400N2P2
CUSIP
F86930108
CIK
-
Shares
802377.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Mr. Stephane Le Roux
Employee Count
-
Website
https://www.spineway.com
Ipo Date
2013-02-13
Details
Spineway SA engages in the design, manufacture, and marketing of implants and surgical instruments for treating disorder of spinal column. The company offers ayers rock, an anterior cervical interbody fusion cage; blue mountain, an anterior cervical interbody fusion plate; mont blanc, a posterior thoracolumbar pedicle screws; mont blanc baby, a pediatric growing rod system; mont blanc 3d+, a coplanar alignment system; kili, an anterior lumbar interbody fusion cage; twin peaks plif bullet shaped posterior lumbar interbody fusion cages; twin peaks olif graft vascularization interbody fusion cages; twin peaks tlif transforaminal lumbar interbody fusion cages; and mont blanc mis, a mini-invasive thoracolumbar system. It also provides sonora, a biomaterial for bone regeneration. In addition, the company exports its products. Spineway SA was incorporated in 2005 and is headquartered in Ecully, France.